Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2011-01-18
2011-01-18
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Vector, per se
C435S252300
Reexamination Certificate
active
07871816
ABSTRACT:
Expression vectors that can efficiently produce virion capsid protein, tumor-associated protein of human papillomavirus on a microbial surface. Bacterial strains harboring such surface display vectors, and the use of the bacterial strains or their extracts or purified products as complex vaccines, are also described. The surface display vectors contain one or more than two genes selected from among pgsB, pgsC and pgsA, encoding a poly-χ-glutamic acid synthetase complex (pgsBCA) of aBacillussp. strain, and genes that encode virion capsid proteins, tumor-associated proteins of human papillomavirus. Methods for preparing the foregoing vectors, vaccines and transformed microorganisms are also described.
REFERENCES:
patent: 2005/0249752 (2005-11-01), Sung et al.
patent: 2001-017182 (2001-01-01), None
patent: 10-2001-0044019 (2001-06-01), None
patent: 10-2004-0032824 (2004-04-01), None
patent: 9901557 (1999-01-01), None
patent: 0075336 (2000-12-01), None
Agterberg, Marja, et al., “Outer membrane PhoE protein ofEscherichia colias a carrier for foreign antigenic determinants: immunology of epitop . . . ”, “Vaccine”, Feb. 1990, pp. 85-91, vol. 8, No. 1.
Ashiuchi, Makoto, et al., “A Poly-gamma-glutamate Synthetic System ofBacillus subtilisIFO 3336: Gene Cloning and Biochemical Analysis of . . . ”, “Biochem. Biophy. Res. Comm.”, Sep. 16, 1999, pp. 6-12, vol. 263, No. 1.
Bubenik, J., et al., “Therapeutic vaccines against HPV16-associated tumors”, “Neoplasma”, 2002, pp. 285-289, vol. 49, No. 5.
Charbit, A., et al., “Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria”, “J. Immunol.”, Sep. 1, 1987, pp. 1658-1664, vol. 139, No. 5.
Felici, Franco, et al., “Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector”, “J. Mol. Biol.”, Nov. 20, 1991, pp. 301-310, vol. 222, No. 2.
Fuchs, P., et al., “Targeting recombinant antibodies to the surface ofExcherichia coli: fusion to a peptidoglycan associated lipoprotein”, “Bio/Technology”, Dec. 1991, pp. 1369-1372, vol. 9, No. 12.
Gao, L., et al., “Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector”, “J. Gen. Virol.”, Jan. 1994, pp. 157-164, vol. 75.
Hagensee, Michael E., et al., “Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the . . . ”, “J. Virol.”, Jan. 1993, pp. 315-322, vol. 67.
Hedegaard, Lisbeth, et al., “Type 1 fimbriae ofEscherichia colias carriers of heterologous antigenic sequences”, “Gene”, Dec. 21, 1989, pp. 115-124, vol. 85, No. 1.
Jung, Heung-Chae, et al., “Surface display ofZymomonas mobilislevansucrase by using the ice-nucleation protein ofPseudomonas syringae”, “Nat. Biotech.”, Jun. 1998, pp. 576-580, vol. 16, No. 6.
Jung, H.C., et al., “Expression of carboxymethylcellulase on the surface ofEscherichia coliusingPseudomonas syringaeice nucleation . . . ”, “Enzyme Microb. Technol.”, Apr. 1998, pp. 348-354, vol. 22, No. 5.
Kornacker, M.G., et al., “The normally periplasmic enzyme beta-lactamase is specifically and efficiently translocated through theEscherchia. . . ”, “Mol. Microbiol.”, Jul. 1990, pp. 1101-1109, vol. 4, No. 7.
Koutsky, Laura A. et al., “A controlled trial of a human papillomavirus type 16 vaccine”, “New England Journal of Medicine”, 2002, pp. 1645-1651, vol. 347, No. 21.
Lee, Jong-Soo, et al., “Surface-displayed viral antigens onSalmonellacarrier vaccine”, “Nat. Biotech.”, Jun. 2000, pp. 645-648, vol. 18, No. 6.
Lehtinen, M., et al., “Efficacy of preventive human papillomavirus vaccination”, “Int. J. STD. AIDS”, Dec. 2001, pp. 771-776, vol. 12, No. 12.
Meneguzzi, et al., “Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7”, “Virology”, 1991, pp. 62-69, vol. 181, No. 1.
Moss, Bernard, “Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety”, “Proc. Natl. Acad. Sci. USA”, Oct. 1996, pp. 11341-11348, vol. 93.
Pfister, H., et al., “Human papillomaviruses and genital cancer”, “Advanced Cancer Research”, 1987, pp. 113-147, vol. 48.
Pisani, P., et al., “Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections . . . ”, “Int. J. Cancer”, 1993, pp. 891-903, vol. 55, No. 6.
Plotkin, Stanley A., M.D., et al., “Vaccines”, “Vaccines”, 1988, p. 571, Publisher: W. B. Saunders Co.
Ressing, et al., “Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro . . . ”, “J. Immunol.”, Jun. 1995, pp. 5934-5943, vol. 154, No. 11.
Schiller, John., et al., “Papillomavirus-like particles and HPV vaccine development”, “Seminars in Cancer Biol.”, Dec. 1996, pp. 373-382, vol. 7, No. 6.
Thanavala, Y., et al., “Immunogenicity of transgenic plant-derived hepatitis B surface antigen”, “Proc. Natl. Acad. Sci. USA”, Apr. 1995, pp. 3358-3361, vol. 92.
Francisco, Joseph A., et al., “Transport and anchoring of beta-lactamase to the external surface ofEscherichia coli”, “Proc. Natl. Acad. Sci. USA”, Apr. 1, 1992, pp. 2713-2717, vol. 89, No. 7.
Lowy, Douglas R., et al., “Genital human papillomavirus infection”, “Proc. Natl. Acad. Sci. USA”, Mar. 1994, pp. 2436-2440, vol. 91.
Meneguzzi, et al., “Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7”, “Virology”, 1991, pp. 62-69, vol. 181, No. 1.
Hong Seung Pyo
Jung Chang Min
Kim Chul-Joong
Lee Jong Soo
Park Sue-nie
Bioleaders Corporation
Hultquist Steven J.
Intellectual Property / Technology Law
Korea Research Institute of Bioscience and Biotechnology
Navarro Mark
LandOfFree
Vector for anti-HPV vaccine and transformed microorganism by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vector for anti-HPV vaccine and transformed microorganism by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vector for anti-HPV vaccine and transformed microorganism by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630795